QSAR Study on 5-Lipoxygenase Activating Protein (FLAP) Inhibitors: The Derivatives of 2,2-Bisaryl-Bicycloheptane

被引:0
|
作者
Sharma, Brij Kishore [1 ]
Pilania, Pradeep [1 ]
Singh, Prithvi [1 ]
机构
[1] SK Govt Coll, Dept Chem, Sikar 332001, India
关键词
2,2-bisaryl-bicycloheptane derivatives; 5-lipoxygenase activating protein (FLAP) inhibitors; Combinatorial protocol in multiple linear regression (CP-MLR); Partial least square (PLS) analysis; LEUKOTRIENE BIOSYNTHESIS INHIBITORS; VARIABLE SELECTION; SUBSTITUTED 2,2-BISARYL-BICYCLOHEPTANES; POTENT; INDOLES; DISEASE; MODELS; ACID;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The FLAP inhibitory activity of 2,2-bisaryl-bicycloheptane derivatives has been quantitatively analyzed in terms of Dragon descriptors. The derived QSAR models have provided rationales to explain the FLAP inhibitory activity of 2,2-bisaryl-bicycloheptane derivatives. The presence of quinolinylmethoxy substituent at R(2)-position in a molecular structure is a crucial feature for the FLAP inhibitory activity. The occurrence of R-CR-X type structural fragment (descriptor C-028) and higher number of sulfur atoms (descriptor nS) in a molecular structure are prevalent to rationalize the FLAP actions of bicycloheptane derivatives. The topological charge indices (descriptors GGI3, 3(rd) order Galvez topological charge index; and JGI4, 4(th) order Galvez mean topological charge index), path/walk ratio 2 (Randic's molecular shape descriptor PW2) and atomic polarizabilities at lag 2 (descriptor GATS2p, Geary autocorrelation of lag 2 weighted by atomic polarizabilities) are also important to explain the FLAP activity. The PLS analysis has also confirmed the dominance of information content of CP-MLR identified descriptors. Applicability domain analysis revealed that the suggested model matches the high quality parameters with good fitting power and the capability of assessing external data, and all of the compounds were within the applicability domain of the proposed models and were evaluated correctly.
引用
收藏
页码:32 / 43
页数:12
相关论文
共 50 条
  • [21] QSAR study on 5-lipoxygenase inhibitors using distance-based topological indices
    Agrawal, VK
    Bano, S
    Khadikar, PV
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (24) : 5519 - 5527
  • [22] A Single Amino Acid Difference between Mouse and Human 5-Lipoxygenase Activating Protein (FLAP) Explains the Speciation and Differential Pharmacology of Novel FLAP Inhibitors
    Blevitt, Jonathan M.
    Hack, Michael D.
    Herman, Krystal
    Chang, Leon
    Keith, John M.
    Mirzadegan, Tara
    Rao, Navin L.
    Lebsack, Alec D.
    Milla, Marcos E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (24) : 12724 - 12731
  • [23] Discovery of AZD6642, an Inhibitor of 5-Lipoxygenase Activating Protein (FLAP) for the Treatment of Inflammatory Diseases
    Lemurell, Malin
    Ulander, Johan
    Winiwarter, Susanne
    Dahlen, Anders
    Davidsson, Oejvind
    Emtenaes, Hans
    Broddefalk, Johan
    Swanson, Marianne
    Hovdal, Daniel
    Plowright, Alleyn T.
    Pettersen, Anna
    Ryden-Landergren, Marie
    Barlind, Jonas
    Llinas, Antonio
    Hersloef, Margareta
    Drmota, Tomas
    Sigfridsson, Kalle
    Moses, Sara
    Whatling, Carl
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (02) : 897 - 911
  • [24] Application of Wavelet and Genetic Algorithms for QSAR Study on 5-Lipoxygenase Inhibitors and Design New Compounds
    Shahri, Fatemeh Bagheban
    Niazi, Ali
    Akrami, Ahmad
    JOURNAL OF THE MEXICAN CHEMICAL SOCIETY, 2015, 59 (03) : 203 - 210
  • [25] Glomerular localization of 5-lipoxygenase and (5-LO) activating protein (FLAP) in a rat model of proliferative glomerulonephritis (GN).
    Uda, S
    Munger, KA
    Badr, KF
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A1936 - A1936
  • [26] Identification of Novel 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors by an Integrated Method of Pharmacophore Virtual Screening, Docking, QSAR and ADMET Analyses
    Rullah, Kamal
    Roney, Miah
    Ibrahim, Zalikha
    Shamsudin, Nur Farisya
    Islami, Deri
    Ahmed, Qamar Uddin
    Wai, Lam Kok
    Aluwi, Mohd Fadhlizil Fasihi Mohd
    JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY, 2023, 22 (01): : 77 - 97
  • [27] Identification of novel benzimidazole derivatives as inhibitors of leukotriene biosynthesis by virtual screening targeting 5-lipoxygenase-activating protein (FLAP)
    Banoglu, Erden
    Caliskan, Burcu
    Luderer, Susann
    Eren, Gokcen
    Ozkan, Yagmur
    Altenhofen, Wolfram
    Weinigel, Christina
    Barz, Dagmar
    Gerstmeier, Jana
    Pergola, Carlo
    Werz, Oliver
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (12) : 3728 - 3741
  • [28] Early Development Scale-Up of a Structurally-Challenging 5-Lipoxygenase Activating Protein (FLAP) Inhibitor
    Mulder, Jason A.
    Gao, Joe
    Fandrick, Keith R.
    Zeng, Xingzhong
    Desrosiers, Jean-Nicolas
    Patel, Nitinchandra D.
    Li, Zhibin
    Rodriguez, Sonia
    Lorenz, Jon C.
    Wang, Jun
    Ma, Shengli
    Fandrick, Daniel R.
    Grinberg, Nelu
    Lee, Heewon
    Bosanac, Todd
    Takahashi, Hidenori
    Chen, Zhidong
    Bartolozzi, Alessandra
    Nemoto, Peter
    Busacca, Carl A.
    Song, Jinhua J.
    Yee, Nathan K.
    Mahoney, Paige E.
    Senanayake, Chris H.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2017, 21 (09) : 1427 - 1434
  • [29] From lead to candidate drug selection of AZD6642, a 5-lipoxygenase activating protein (FLAP) inhibitor
    Lemurell, Malin
    Barlind, Jonas
    Broddefalk, Johan
    Dahlen, Anders
    Davidsson, Ojvind
    Drmota, Tomas
    Emtenas, Hans
    Hersof, Margareta
    Hovdal, Daniel
    Linas, Antonio
    Moses, Sara
    Plowright, Alleyn
    Sigfridsson, Carl-Gustav
    Swanson, Marianne
    Ulander, Johan
    Whatling, Carl
    Winiwarter, Susanne
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [30] THIOPYRANOL[2,3,4-C,D] INDOLES AS INHIBITORS OF 5-LIPOXYGENASE, 5-LIPOXYGENASE-ACTIVATING PROTEIN, AND LEUKOTRIENE C-4 SYNTHASE
    HUTCHINSON, JH
    CHARLESON, S
    EVANS, JF
    FALGUEYRET, JP
    HOOGSTEEN, K
    JONES, TR
    KARGMAN, S
    MACDONALD, D
    MCFARLANE, CS
    NICHOLSON, DW
    PIECHUTA, H
    RIENDEAU, D
    SCHEIGETZ, J
    THERIEN, M
    GIRARD, Y
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (22) : 4538 - 4547